Proper training prior to first use of NEXPLANON can minimize the risk of improper NEXPLANON insertion. Because of the risk of complications due to improper insertion and removal NEXPLANON is available ...
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque Organon (NYSE: OGN), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results